Early trials found that both garadacimab and sebetralstat were safe when used in patients living with hereditary angioedema, which speaks to the promise of the FDA-approved garadacimab. The recent ...

The recent approval of garadacimab can help to treat patients with hereditary angioedema (HAE) along with sebetralstat, which is awaiting FDA approval, explains Timothy Craig, DO, Penn State Health.

Please provide your email address to receive an email when new articles are posted on . Garadacimab-gxii inhibits factor XIIa at the top of the HAE cascade. 62% of patients were attack-free during the ...